Ruth Palmer Lab
Ruth Palmer Lab
News
People
Events
Publications
Contact
Funding
Joachim Tetteh Siaw
Latest
RUVBL1 and RUVBL2 are druggable MYC effector regulators in neuroblastoma cells
ATR inhibition enables complete tumour regression in ALK-driven NB mouse models
11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib
Cite
×